WallStreetZenWallStreetZen

NYSEMKT: PTHS
Pelthos Therapeutics Inc Stock Ownership - Who owns Pelthos Therapeutics?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Pelthos Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Todd C. DavisDirector2025-07-011,500,000$10.00
$15.00MBuy
Knuettel Francis IiChief Financial Officer2025-07-0110,000$10.00
$100.00kBuy
Ezra M. FriedbergDirector2025-07-0140,000$10.00
$400.00kBuy
Ezra M. FriedbergDirector2025-07-0140,000$10.00
$400.00kBuy
Ligand Pharmaceuticals Inc10% Owner2025-07-011,500,000$10.00
$15.00MBuy
Knuettel Francis IiCEO Pres. CFO Treas Secty2024-09-133,500$0.97
$3.40kBuy
Richard MalamutDirector2024-09-1210,400$0.95
$9.83kBuy
Knuettel Francis IiCEO Pres. CFO Treas Secty2024-09-121,700$0.97
$1.65kBuy
Knuettel Francis IiCEO Pres. CFO Treas Secty2024-09-115,500$0.94
$5.17kBuy
Knuettel Francis IiCEO Pres. CFO Treas Secty2024-09-106,500$0.89
$5.79kBuy

1 of 1

PTHS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PTHS insiders and whales buy or sell their stock.

PTHS Shareholders

What type of owners hold Pelthos Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Todd C. Davis227.86%1,502,917$24.32MInsider
Ligand Pharmaceuticals Inc227.42%1,500,000$24.28MInsider
Ezra M. Friedberg99.35%655,292$10.61MInsider
Motif Pharmaceuticals Ltd71.36%470,674$7.62MInsider
Boswell Prayer Ltd69.72%459,895$7.44MInsider
Ikarian Capital LLC66.84%440,849$7.14MInstitution
Aperture Healthcare Ventures Ltd64.67%426,566$6.90MInsider
Ame Equities LLC53.24%351,163$5.68MInsider
Knuettel Francis Ii23.31%153,769$2.49MInsider
Boothbay Fund Management LLC19.82%130,754$2.12MInstitution

1 of 2

PTHS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PTHS9.60%90.40%Net BuyingNet Buying
CSCI0.86%0.00%
CYCN11.60%88.40%Net Selling
TAOX3.75%11.31%Net SellingNet Selling
XFOR93.26%6.74%Net SellingNet Buying
View Top Biotech Stocks

Pelthos Therapeutics Stock Ownership FAQ

Who owns Pelthos Therapeutics?

Pelthos Therapeutics (NYSEMKT: PTHS) is owned by 90.34% institutional shareholders, 850.81% Pelthos Therapeutics insiders, and 0.00% retail investors. Todd C. Davis is the largest individual Pelthos Therapeutics shareholder, owning 1.50M shares representing 227.86% of the company. Todd C. Davis's Pelthos Therapeutics shares are currently valued at $24.32M.

If you're new to stock investing, here's how to buy Pelthos Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.